A method for quickly constructing a single-plasmid T7 expression system
By predicting and adjusting the lethal upper limit of T7 RNAP in the single-plasmid T7 expression system, the problems of complexity and long construction time in the application of T7 expression system in non-model hosts are solved, realizing rapid and customized construction of single-plasmid T7 expression system, reducing host mortality risk and improving construction success rate.
Patent Information
- Application Number
- CN202310685766.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-09
- Publication Date
- 2026-06-23
- Estimated Expiration
- 2043-06-09
AI Technical Summary
In existing technologies, the application of T7 expression systems in non-model hosts is complex. The construction of single-plasmid T7 expression systems is time-consuming and has a low success rate. Furthermore, host bacteria are prone to death due to overexpression of T7 RNAP.
This paper presents a method for rapidly constructing a single-plasmid T7 expression system based on the modular concept of synthetic biology. By predicting the lethal upper limit of T7 RNAP in the host, the DNA structure of the T7 RNAP expression unit is adjusted, including changing the promoter, RBS, codon, terminator, plasmid copy number, etc., and inserting antisense RNA and transcription interference structures to achieve host-specific and customized construction.
This method enables the rapid construction of single-plasmid T7 expression systems in different hosts, reduces T7 RNAP expression levels and activity, improves construction success rate, simplifies the operation process, and provides a convenient method for applying T7 expression systems to non-model strains.